Artivion (AORT) Tops Q3 EPS by 8c; Offers FY23 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- S&P 500 up, Nasdaq at record high as megacap tech stocks rise
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Alaska LNG shipping savings justifies billions in investment, developer says
- Citi cuts investment banking analyst program to two years - Bloomberg
- S&P 500 up, Nasdaq at record high as megacap tech stocks rise
- Paramount Skydance to close WBD deal, change ticker to SKYD
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
Artivion Reports Third Quarter 2023 Financial Results
November 2, 2023 4:05 PM EDTThird Quarter and Recent Business Highlights:
Achieved revenue of $87.9 million in the third quarter of 2023 versus $76.8 million in the third quarter of 2022, an increase of 14% on a GAAP basis and 12% on a non-GAAP constant currency basisNet loss was ($9.8) million or ($0.24) per share; non-GAAP net income was $749,000 or $0.02 per shareNon-GAAP adjusted EBITDA increased 34% to $13.9 million in the third quarter of 2023 compared to the third quarter of 2022Aortic stent graft revenues... More


